247 related articles for article (PubMed ID: 29143277)
1. Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma.
Nagashima H; Sasayama T; Tanaka K; Kyotani K; Sato N; Maeyama M; Kohta M; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
J Neurooncol; 2018 Jan; 136(2):317-326. PubMed ID: 29143277
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging and Proton Magnetic Resonance Spectroscopy for Differentiating Between Enhanced Gliomas and Malignant Lymphomas.
Ohba S; Murayama K; Abe M; Hasegawa M; Hirose Y
World Neurosurg; 2019 Jul; 127():e779-e787. PubMed ID: 30951915
[TBL] [Abstract][Full Text] [Related]
3. Diffusional kurtosis imaging for differentiating between high-grade glioma and primary central nervous system lymphoma.
Pang H; Ren Y; Dang X; Feng X; Yao Z; Wu J; Yao C; Di N; Ghinda DC; Zhang Y
J Magn Reson Imaging; 2016 Jul; 44(1):30-40. PubMed ID: 26588793
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma.
Yamasaki F; Takayasu T; Nosaka R; Amatya VJ; Doskaliyev A; Akiyama Y; Tominaga A; Takeshima Y; Sugiyama K; Kurisu K
J Neurosurg; 2015 Jun; 122(6):1370-9. PubMed ID: 25748300
[TBL] [Abstract][Full Text] [Related]
5. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
6. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of Primary Central Nervous System Lymphoma and High-Grade Glioma with Dynamic Susceptibility Contrast-Derived Metrics: Pilot Study.
Chaganti J; Taylor M; Woodford H; Steel T
World Neurosurg; 2021 Jul; 151():e979-e987. PubMed ID: 34020062
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging.
Ding Y; Xing Z; Liu B; Lin X; Cao D
Brain Behav; 2014; 4(6):841-9. PubMed ID: 25365807
[TBL] [Abstract][Full Text] [Related]
9. Potential of MR spectroscopy for assessment of glioma grading.
Bulik M; Jancalek R; Vanicek J; Skoch A; Mechl M
Clin Neurol Neurosurg; 2013 Feb; 115(2):146-53. PubMed ID: 23237636
[TBL] [Abstract][Full Text] [Related]
10. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
[TBL] [Abstract][Full Text] [Related]
11. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma.
Nagashima H; Tanaka K; Sasayama T; Irino Y; Sato N; Takeuchi Y; Kyotani K; Mukasa A; Mizukawa K; Sakata J; Yamamoto Y; Hosoda K; Itoh T; Sasaki R; Kohmura E
Neuro Oncol; 2016 Nov; 18(11):1559-1568. PubMed ID: 27154922
[TBL] [Abstract][Full Text] [Related]
14. Brain Glioma Localization Diagnosis Based on Magnetic Resonance Imaging.
Jin Y; Peng H; Peng J
World Neurosurg; 2021 May; 149():325-332. PubMed ID: 32992057
[TBL] [Abstract][Full Text] [Related]
15. Low-grade glioma: correlation of short echo time 1H-MR spectroscopy with 23Na MR imaging.
Bartha R; Megyesi JF; Watling CJ
AJNR Am J Neuroradiol; 2008 Mar; 29(3):464-70. PubMed ID: 18238848
[TBL] [Abstract][Full Text] [Related]
16. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
[TBL] [Abstract][Full Text] [Related]
17. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of Susceptibility-Weighted Imaging and Dynamic Susceptibility Contrast Magnetic Resonance Imaging for Differentiating High-Grade Glioma from Primary Central Nervous System Lymphomas: Meta-Analysis.
Wu Y; Den Z; Lin Y
World Neurosurg; 2018 Apr; 112():e617-e623. PubMed ID: 29371168
[TBL] [Abstract][Full Text] [Related]
19. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
Kinoshita Y; Yokota A
NMR Biomed; 1997 Jan; 10(1):2-12. PubMed ID: 9251109
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]